In this study, 516 women with an ovarian mass on pelvic imaging were evaluated with the American College of Obstetricians and Gynecologists' (ACOG) Ovarian Tumor Referral Guidelines. It was demonstrated that replacing CA-125 serum testing of the ACOG guidelines with OVA1 increased the overall sensitivity to cancer and negative predictive value. ACOG guidelines recommend preoperative consultation with a gynecologic oncologist for one or more of following criteria: 
Overview
In this study, 516 women with an ovarian mass on pelvic imaging were evaluated with the American College of Obstetricians and Gynecologists' (ACOG) Ovarian Tumor Referral Guidelines. It was demonstrated that replacing CA-125 serum testing of the ACOG guidelines with OVA1 increased the overall sensitivity to cancer and negative predictive value. ACOG guidelines recommend preoperative consultation with a gynecologic oncologist for one or more of following criteria: 
Key Results
• ACOG guidelines with OVA1 identified 27 malignancies missed by ACOG guidelines with CA-125 (161 total malignancies in cohort)
• Replacing CA-125 with OVA1 in the ACOG guidelines increased detection of early stage ovarian cancer from 73% to 96%
• The improvement in cancer detection was most notable for premenopausal women
• Using ACOG guidelines with OVA1 led to an increase in sensitivity (94%) and negative predictive value (93%), and decrease in the specificity (35%) and positive predictive value (40%)
Conclusion
Using OVA1 instead of CA-125 in the ACOG guidelines will identify more malignancies before surgery, particularly for premenopausal women and early-stage disease.
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